GLP-1 drugs are dosed low and stepped up slowly — usually about every four weeks, but only once you tolerate each dose. Inject once weekly on a consistent day, at any time, rotating between abdomen, thigh, or upper arm. If you miss a dose, take semaglutide within about 5 days and tirzepatide within about 4 days; otherwise skip it. Always follow your specific product label and never adjust doses or split pens without your prescriber.
Key takeaways
- Titration starts low to limit GI side effects; you typically step up about every 4 weeks, but only if you're tolerating the dose.
- There's no rule you must escalate — staying longer at a dose is fine if it's working and tolerable.
- Inject once weekly on a consistent day, any time of day; most labels allow changing the day if it's been at least 48–72 hours.
- Abdomen, thigh, and upper arm all work; rotate sites — absorption is comparable.
- Missed dose: semaglutide ~5 days, tirzepatide ~4 days, otherwise skip. Never double up.
- Microdosing and splitting pens are not manufacturer-approved and carry real risks — talk to a clinician.
How does GLP-1 titration work and when do I move up?
Every GLP-1 medication is started at a low dose that is below the dose that actually treats your diabetes or drives weight loss. This starting dose exists purely to let your body adjust. The most common side effects — nausea, vomiting, diarrhea and constipation — happen because the drug slows your digestion, and they're worst right after a dose increase. Starting low and going slow gives your gut time to adapt, which is why this gradual ramp-up is called titration.
As a general rule, you stay at each dose for about four weeks before stepping up to the next one. But the four-week interval is a floor, not a deadline. The single most important principle of titration is this: you move up only when you're tolerating your current dose well. If you're still battling significant nausea, your clinician will usually keep you at the current dose longer rather than push you higher.
It's equally important to know the reverse: there is no rule that you must keep escalating. If your current dose is controlling your appetite or blood sugar, you're still losing weight, and side effects are manageable, it's completely reasonable to stay where you are. Many people reach a dose that works for them well before the maximum and simply stay there. The "target" or maximum dose on the label is the highest dose studied — not a goal everyone has to reach.
Because escalation affects side effects, blood sugar, and cost, dose changes should always be made with your prescriber, not on your own. If side effects are intolerable at a new dose, clinicians can also step back down to the last dose you tolerated and try again later.
What time of day and which day should I inject?
For the weekly injectable GLP-1 drugs, time of day does not matter — you can inject morning, noon, or night, with or without food. Pick whatever you'll remember consistently.
What does matter is picking a consistent day of the week and sticking to it, because these are once-weekly medications designed to maintain steady drug levels. Choosing a day you're reliably home and not rushed (many people pick Sunday) makes it easier to never miss.
Life happens, though, and you may need to shift your injection day. Most product labels allow you to change the day of the week as long as it has been at least 48 to 72 hours since your last dose (the exact minimum gap depends on the product). After changing, you continue with the new day going forward. Check your specific label, or ask your pharmacist, before shifting your schedule.
Does the injection site matter?
GLP-1 injections are subcutaneous — they go into the fatty tissue just under the skin, not into muscle. There are three approved injection sites, and all are acceptable: the abdomen (avoiding a couple of inches around the navel), the front of the thigh, and the back of the upper arm. Absorption is comparable across these sites, so there's no "best" spot for effectiveness.
Two habits make injections more comfortable and reduce skin problems:
- Rotate your sites with each injection rather than using the same exact spot every week. Repeated injections in one area can cause lumps or changes in the fatty tissue.
- Avoid skin that's bruised, tender, red, hard, or scarred, and don't inject through clothing.
What should I do if I miss a dose?
This is one of the most common GLP-1 questions, and the answer depends on which drug you take — so the rules below are general, and your label is the final word.
- Semaglutide (Ozempic, Wegovy): If you remember within about 5 days of the missed dose, take it as soon as you can, then continue on your regular weekly day. If more than ~5 days have passed, skip the missed dose entirely and take your next dose on the normal scheduled day.
- Tirzepatide (Mounjaro, Zepbound): If you remember within about 4 days, take the missed dose; if more than ~4 days have passed, skip it and resume your normal schedule.
Never take two doses close together to "catch up." Doubling up dramatically increases nausea, vomiting, and other side effects without any benefit. If you've missed several weeks in a row, contact your prescriber — you may need to restart at a lower dose rather than jumping back to your previous one. For a drug-by-drug walkthrough, see exactly what to do if you miss a GLP-1 dose.
Titration and missed-dose at a glance
| Topic | Semaglutide (Ozempic / Wegovy) | Tirzepatide (Mounjaro / Zepbound) |
|---|---|---|
| Frequency | Once weekly | Once weekly |
| Typical step-up interval | ~Every 4 weeks, as tolerated | ~Every 4 weeks, as tolerated |
| Time of day | Any time, with or without food | Any time, with or without food |
| Changing injection day | Allowed if ≥48–72 hrs since last dose* | Allowed if ≥72 hrs since last dose* |
| Missed-dose window | Take within ~5 days, else skip | Take within ~4 days, else skip |
| Doubling up? | Never | Never |
*Minimum gaps and windows are approximate and vary by product. Always confirm against the FDA label or medication guide for your exact drug. See our medications guide for the full lineup.
How long can pens and vials stay at room temperature?
Before first use, GLP-1 pens and vials should be stored in the refrigerator (not frozen). Once you start using a pen, most products can be kept at room temperature for a limited period — for some pens this is roughly a few weeks — which makes travel and daily handling easier.
The exact room-temperature limit, the acceptable temperature range, and whether the in-use pen can go back in the fridge all vary by product, so the specific number on your label is what counts. A few universal rules:
- Never freeze a GLP-1 product, and don't use it if you suspect it has frozen.
- Discard any pen or vial that has been kept beyond its room-temperature limit or exposed to heat (such as a hot car or direct sun).
- Keep pens with the cap on, protected from light, until use.
What is "microdosing" and is it safe?
Microdosing refers to deliberately using smaller-than-standard doses of a GLP-1 drug — for example, taking a fraction of a normal dose. People do it anecdotally to try to limit side effects or to stretch a limited or expensive supply of medication.
Here's the honest picture: microdosing is not an FDA-approved strategy and has not been well studied in clinical trials. The standard doses are the ones tested for safety and effectiveness; whether a much smaller dose works, and how to do it safely, simply isn't established. Microdosing also often goes hand-in-hand with splitting pens or vials, which adds its own risks (below). If you're considering a non-standard dose for cost or tolerability reasons, raise it with your clinician — there are often label-approved ways to manage side effects or lower cost instead.
Is splitting a pen or vial to make it last longer safe?
Some people draw smaller amounts from a pen or vial to make a supply last longer, almost always to save money. It's understandable given the cost of these drugs, but it carries real risks and is not manufacturer-recommended:
- Dosing errors. Pens are engineered to deliver precise doses; drawing your own amounts (especially from a pen not designed for it) makes it easy to take too much or too little.
- Contamination. Repeatedly accessing a vial or repurposing a device increases the risk of introducing bacteria, particularly without sterile technique.
- Product integrity. Manipulating the device can affect dose accuracy and sterility in ways the manufacturer never tested.
If cost is the issue, look at manufacturer savings programs, approved lower-cost options, and coverage strategies in our cost and insurance guide rather than improvising with the device.
Can I switch from semaglutide to tirzepatide (or vice versa)?
Yes — switching between GLP-1 drugs in either direction is common and is done under a clinician's guidance. People switch for many reasons: side effects, cost and coverage changes, supply, or a plateau in results.
The key technical point is that the drugs are not dose-equivalent, so you don't match milligram for milligram. In practice, you usually restart at a low dose of the new drug and titrate up, just as you would when starting fresh, rather than jumping to a dose that "feels equivalent" to your old one. This minimizes side effects and lets your body re-adjust. Your prescriber will set the new starting dose and schedule. You can compare the two drugs directly in our Zepbound & Mounjaro guide.
How do I know if my dose is too high?
Some nausea early on is expected and usually fades. But certain signs suggest a dose is too much for you and warrant a call to your prescriber:
- Severe or persistent nausea or vomiting that isn't improving.
- Inability to keep fluids down, which can quickly lead to dehydration.
- Signs of dehydration — dizziness, dark urine, marked fatigue — which can also stress the kidneys.
If you experience these, don't just push through. Contact your prescriber, who may pause your titration, step you back to the last dose you tolerated, or check for other causes. Severe abdominal pain (especially radiating to the back) needs urgent medical attention, as it can signal pancreatitis. Our side effects guide covers warning signs in detail.
The bottom line
Good GLP-1 dosing is mostly about patience and consistency: start low, step up about every four weeks only as you tolerate it, and don't feel pressured to chase the maximum dose if a lower one is working. Inject once a week on a steady day, rotate your sites, store your medication correctly, and know your drug's missed-dose window. Steer clear of unapproved shortcuts like microdosing and pen-splitting, and make every dose change a conversation with your prescriber.
From here, a sensible next step is learning what to eat on GLP-1 to ease side effects, or — if you haven't started yet — how to get a GLP-1 prescription.
Frequently asked questions
When should I move up to the next GLP-1 dose?
Usually after about 4 weeks, and only once you're tolerating your current dose. There's no rule you must escalate — if a lower dose is working and side effects are manageable, it's fine to stay there. Make dose changes with your prescriber.
What happens if I miss my weekly dose?
For semaglutide (Ozempic, Wegovy), take it within about 5 days; for tirzepatide (Mounjaro, Zepbound), within about 4 days. Past that window, skip the dose and resume your schedule. Never double up, and always follow your product label.
Does the injection site matter?
No — the abdomen, thigh, and upper arm are all acceptable and absorb comparably. Rotate sites with each injection, and avoid skin that's bruised, tender, red, or scarred.
What is GLP-1 microdosing and is it safe?
Microdosing means using smaller-than-standard doses, often to limit side effects or stretch supply. It is not FDA-approved and not well studied, so its safety and effectiveness are unproven. Discuss any non-standard dosing with a clinician first.
How long can GLP-1 pens stay at room temperature?
Store them refrigerated. Once in use, room-temperature limits vary by product — roughly a few weeks for some pens — so check your specific label. Discard anything kept beyond its limit or exposed to heat or freezing.
Can I switch from semaglutide to tirzepatide?
Yes, under a clinician's guidance, in either direction. Because the drugs aren't dose-equivalent, you usually restart at a low dose of the new drug and titrate up rather than matching your old dose.
Sources & further reading
- U.S. Food & Drug Administration — prescribing information and medication guide for Ozempic (semaglutide injection).
- U.S. Food & Drug Administration — prescribing information and medication guide for Wegovy (semaglutide injection).
- U.S. Food & Drug Administration — prescribing information and medication guide for Mounjaro (tirzepatide injection).
- U.S. Food & Drug Administration — prescribing information and medication guide for Zepbound (tirzepatide injection).
- Manufacturer storage and handling instructions for semaglutide and tirzepatide pens and vials.